Ceramide-orchestrated signalling in cancer cells - PubMed (original) (raw)

Review

doi: 10.1038/nrc3398. Epub 2012 Dec 13.

Affiliations

• PMID: 23235911
• DOI: 10.1038/nrc3398

Review

Ceramide-orchestrated signalling in cancer cells

Samy A F Morad et al. Nat Rev Cancer. 2013 Jan.

Abstract

One crucial barrier to progress in the treatment of cancer has been the inability to control the balance between cell proliferation and apoptosis: enter ceramide. Discoveries over the past 15 years have elevated this sphingolipid to the lofty position of a regulator of cell fate. Ceramide, it turns out, is a powerful tumour suppressor, potentiating signalling events that drive apoptosis, autophagic responses and cell cycle arrest. However, defects in ceramide generation and metabolism in cancer cells contribute to tumour cell survival and resistance to chemotherapy. This Review focuses on ceramide signalling and the targeting of specific metabolic junctures to amplify the tumour suppressive activities of ceramide. The potential of ceramide-based therapeutics in the treatment of cancer is also discussed.

PubMed Disclaimer

Similar articles

• A review of ceramide analogs as potential anticancer agents.
  Liu J, Beckman BS, Foroozesh M. Liu J, et al. Future Med Chem. 2013 Aug;5(12):1405-21. doi: 10.4155/fmc.13.107. Future Med Chem. 2013. PMID: 23919551 Free PMC article. Review.
• Tumor suppressive functions of ceramide: evidence and mechanisms.
  Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Galadari S, et al. Apoptosis. 2015 May;20(5):689-711. doi: 10.1007/s10495-015-1109-1. Apoptosis. 2015. PMID: 25702155 Review.
• Ceramide Signaling and p53 Pathways.
  Jeffries KA, Krupenko NI. Jeffries KA, et al. Adv Cancer Res. 2018;140:191-215. doi: 10.1016/bs.acr.2018.04.011. Epub 2018 Jun 1. Adv Cancer Res. 2018. PMID: 30060809 Free PMC article. Review.
• Metabolism of short-chain ceramide by human cancer cells--implications for therapeutic approaches.
  Chapman JV, Gouazé-Andersson V, Messner MC, Flowers M, Karimi R, Kester M, Barth BM, Liu X, Liu YY, Giuliano AE, Cabot MC. Chapman JV, et al. Biochem Pharmacol. 2010 Aug 1;80(3):308-15. doi: 10.1016/j.bcp.2010.04.001. Epub 2010 Apr 10. Biochem Pharmacol. 2010. PMID: 20385104 Free PMC article.
• Targeting ceramide metabolism--a strategy for overcoming drug resistance.
  Senchenkov A, Litvak DA, Cabot MC. Senchenkov A, et al. J Natl Cancer Inst. 2001 Mar 7;93(5):347-57. doi: 10.1093/jnci/93.5.347. J Natl Cancer Inst. 2001. PMID: 11238696 Review.

Cited by

• Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia.
  Ung J, Tan SF, Fox TE, Shaw JJP, Taori M, Horton BJ, Golla U, Sharma A, Szulc ZM, Wang HG, Chalfant CE, Cabot MC, Claxton DF, Loughran TP Jr, Feith DJ. Ung J, et al. Cancers (Basel). 2023 Dec 15;15(24):5866. doi: 10.3390/cancers15245866. Cancers (Basel). 2023. PMID: 38136410 Free PMC article.
• The SwissLipids knowledgebase for lipid biology.
  Aimo L, Liechti R, Hyka-Nouspikel N, Niknejad A, Gleizes A, Götz L, Kuznetsov D, David FP, van der Goot FG, Riezman H, Bougueleret L, Xenarios I, Bridge A. Aimo L, et al. Bioinformatics. 2015 Sep 1;31(17):2860-6. doi: 10.1093/bioinformatics/btv285. Epub 2015 May 5. Bioinformatics. 2015. PMID: 25943471 Free PMC article.
• Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells.
  Hawkins CC, Jones AB, Gordon ER, Harsh Y, Ziebro JK, Willey CD, Griguer C, Crossman DK, Cooper SJ, Ramanadham S, Doan N, Hjelmeland AB. Hawkins CC, et al. Cell Death Discov. 2023 Dec 12;9(1):451. doi: 10.1038/s41420-023-01738-x. Cell Death Discov. 2023. PMID: 38086808 Free PMC article.
• Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells.
  Rajput K, Ansari MN, Jha SK, Pani T, Medatwal N, Chattopadhyay S, Bajaj A, Dasgupta U. Rajput K, et al. Cancers (Basel). 2022 Sep 16;14(18):4496. doi: 10.3390/cancers14184496. Cancers (Basel). 2022. PMID: 36139656 Free PMC article.
• Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia.
  Barth BM, Wang W, Toran PT, Fox TE, Annageldiyev C, Ondrasik RM, Keasey NR, Brown TJ, Devine VG, Sullivan EC, Cote AL, Papakotsi V, Tan SF, Shanmugavelandy SS, Deering TG, Needle DB, Stern ST, Zhu J, Liao J, Viny AD, Feith DJ, Levine RL, Wang HG, Loughran TP Jr, Sharma A, Kester M, Claxton DF. Barth BM, et al. Blood Adv. 2019 Sep 10;3(17):2598-2603. doi: 10.1182/bloodadvances.2018021295. Blood Adv. 2019. PMID: 31488436 Free PMC article.

References

1. 1. Oncogene. 2002 Jun 6;21(25):4009-19 - PubMed
2. 1. Cancer Res. 2003 Mar 15;63(6):1365-70 - PubMed
3. 1. Apoptosis. 2007 Aug;12(8):1533-41 - PubMed
4. 1. Cancer Chemother Pharmacol. 2001 May;47(5):444-50 - PubMed
5. 1. Biochem Biophys Res Commun. 1998 Jan 6;242(1):129-33 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal